JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Lindsay Corp
LNN
$1.16B
| $4.68M | ﹤0.01% |
39,739
-60,238
| -60% | -$7.25M |
2013 Q2
50 quarters
|
|
3252
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.62B
| $4.68M | ﹤0.01% |
38,930
-4,993
| -11% | -$599K |
2017 Q3
33 quarters
|
|
|
RCLO
3253
Reckoner BBB-B CLO ETF
RCLO
$30M
| $4.67M | ﹤0.01% |
+186,052
| New | +$4.68M |
2025 Q4
0 quarters
|
|
3254
Compass Therapeutics
CMPX
$154M
| $4.67M | ﹤0.01% |
870,014
-1,129,264
| -56% | -$5.21M |
2023 Q1
11 quarters
|
|
|
ITWO
3255
ProShares Russell 2000 High Income ETF
ITWO
$186M
| $4.67M | ﹤0.01% |
117,612
| – | – |
2024 Q3
5 quarters
|
|
3256
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.42B
| $4.66M | ﹤0.01% |
93,226
+7,686
| +9% | +$384K |
2023 Q2
10 quarters
|
|
3257
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
| $4.66M | ﹤0.01% |
52,025
-7,395
| -12% | -$658K |
2020 Q4
20 quarters
|
|
|
ORBS
3258
Eightco Holdings
ORBS
$499M
| $4.66M | ﹤0.01% |
2,691,948
+2,687,786
| +64,579% | +$12.6M |
2025 Q3
1 quarter
|
|
3259
Xencor
XNCR
$1.85B
| $4.65M | ﹤0.01% |
303,979
-97,522
| -24% | -$1.46M |
2013 Q4
48 quarters
|
|
3260
ICL Group
ICL
$6.51B
| $4.65M | ﹤0.01% |
814,526
-1,188,879
| -59% | -$6.88M |
2014 Q3
45 quarters
|
|
3261
Tarsus Pharmaceuticals
TARS
$3.42B
| $4.64M | ﹤0.01% |
56,646
-20,544
| -27% | -$1.53M |
2020 Q4
20 quarters
|
|
3262
CALL
Rivian
RIVN
$20.7B
| $4.63M | ﹤0.01% |
235,100
-39,900
| -15% | -$633K |
2023 Q4
8 quarters
|
|
3263
PUT
PNC Financial Services
PNC
$88.2B
| $4.63M | ﹤0.01% |
22,200
| – | – |
2021 Q2
18 quarters
|
|
3264
ORIX
IX
$38.6B
| $4.63M | ﹤0.01% |
158,513
-10,588
| -6% | -$280K |
2013 Q2
50 quarters
|
|
|
MATE
3265
Man Active Trend Enhanced ETF
MATE
$42.1M
| $4.63M | ﹤0.01% |
+178,944
| New | +$4.64M |
2025 Q4
0 quarters
|
|
3266
The Greenbrier Companies
GBX
$1.26B
| $4.61M | ﹤0.01% |
98,646
-57,126
| -37% | -$2.56M |
2014 Q3
45 quarters
|
|
|
CHCT
3267
Community Healthcare Trust
CHCT
$390M
| $4.6M | ﹤0.01% |
280,268
-158,149
| -36% | -$2.36M |
2016 Q1
39 quarters
|
|
3268
Li Auto
LI
$10.4B
| $4.6M | ﹤0.01% |
271,623
+266,852
| +5,593% | +$5.29M |
2020 Q3
21 quarters
|
|
3269
Ingevity
NGVT
$2.49B
| $4.6M | ﹤0.01% |
77,698
-48,382
| -38% | -$2.63M |
2016 Q2
38 quarters
|
|
3270
Navios Maritime Partners
NMM
$2.68B
| $4.59M | ﹤0.01% |
87,535
+52,651
| +151% | +$2.61M |
2021 Q1
19 quarters
|
|
|
MOFG
3271
DELISTED
MidWestOne Financial Group
MOFG
| $4.58M | ﹤0.01% |
119,067
-22,604
| -16% | -$824K |
2016 Q4
36 quarters
|
|
3272
Dime Commercial Bancshares
DCOM
$1.76B
| $4.58M | ﹤0.01% |
152,322
-5,490
| -3% | -$159K |
2013 Q2
50 quarters
|
|
3273
Veeco
VECO
$3.51B
| $4.57M | ﹤0.01% |
160,013
-12,585
| -7% | -$373K |
2016 Q3
37 quarters
|
|
3274
Embecta
EMBC
$320M
| $4.56M | ﹤0.01% |
383,675
-51,147
| -12% | -$674K |
2022 Q2
14 quarters
|
|
3275
Vitesse Energy
VTS
$710M
| $4.55M | ﹤0.01% |
236,028
+27,778
| +13% | +$593K |
2023 Q1
11 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.